Fluticasone furoate maintains epithelial homeostasis via leptin/leptin receptor pathway in nasal cells Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
Lack of effect of beclomethasone dipropionate on EGF-R expression in human nasal epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001
Inhibitory activities of fluticasone propionate and salmeterol on airway epithelial cell functions (FLIC24): adhesion molecule expression and cytokine release Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
Lack of glucocorticoid receptor activation by formoterol and salmeterol in human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Fluticasone furoate, a novel corticosteroid, maintains glucocorticoid receptor nuclear localisation for 24 hours after washout in monocytes Source: Annual Congress 2011 - Translational models of disease Year: 2011
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Effects of mometasone and formoterol on the innate immunity of human gingival epithelial cells Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Inhibitory activity of mometasone furoate and dexamethasone on Mac-1 expression and locomotion of eosinophils from asthmatics subjects Source: Eur Respir J 2002; 20: Suppl. 38, 382s Year: 2002
Inhibitory activity of fluticasone propionate (FP), on the constitutive or cytokine-induced bronchial epithelial cell (HBECs) functions in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003
Nasal fibroblast functions involved in airway inflammation and remodelling are downregulated by fluticasone propionate (FP) Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001
Fluticasone propionate is as potent but more receptor-selective than mometasone furoate Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects Source: Eur Respir J 2002; 19: 257-266 Year: 2002
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression Source: Eur Respir J 2001; 18: 139-145 Year: 2001
Initial interaction of fluticasone propionate with ciliated respiratory epithelium Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
A comparison of fluticasone propionate (FP) and mometasone furoate (MF) nasal spray in the treatment of nasal polyposis associated with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006
Attenuated cytokine response and enhanced toll-like receptor expression by budesonide in bronchial epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006
Anti-inflammatory effect of beclomethasone dipropionate and formoterol on TNF-α-induced human endothelial cell activation Source: Annual Congress 2011 - Lung cell biology Year: 2011